Catégories
Documents disponibles dans cette catégorie (32)
Article : texte imprimé
Lisa H. Amir, Auteur ; Kath Ryan, Auteur ; Clare Barnett, Auteur |Introduction: There are currently no common guidelines used by health professionals to aid decision-making around the use of medicines during breastfeeding. Several specialized books, Web sites, and drug information services exist; however, all [...]texte imprimé
Article : texte imprimé
Drugs are not the preferred method of weight loss, and information on them during breastfeeding is almost nonexistent. Several of them might cause adverse effects on the infant or on lactation itself. Nonabsorbable products such as orlistat and [...]Article : texte imprimé
Several genetic diseases have had advances in treatment, including some new drugs. This column will focus on a few of these drug therapies and their implications for breastfeeding. More detailed information and references on specific drugs can b[...]Article : texte imprimé
Raynaud's phenomenon (RP) occurs in 35% of the population, with the rate of occurrence in women about four times that in men. It is caused by vasospasm of the blood vessels in the extremities, including the nipple. RP of the nipple can be extre[...]Article : texte imprimé
Drug treatment of RA need not be a barrier to breastfeeding; however, careful drug selection is important. Low-dose methotrexate is a mainstay of therapy, and limited data have found no indication of toxicity in breastfed infants, but more data [...]Article : texte imprimé
The Academy Breastfeeding Medicine (ABM) protocols have been accepted worldwide as the standard guide both for clinicians in how to manage the maternalinfant breastfeeding dyad and for the public health system in how to create a breastfeeding s[...]Article : texte imprimé
Jumpei Saito, Auteur ; Naho Yakuwa, Auteur ; Aiko Sasaki, Auteur |Background: Emedastine difumarate is a second-generation antihistamine that is more effective for nasal congestion than first-generation antihistamines. The oral form of emedastine is used for the treatment of allergic rhinitis (AR). However, da[...]Article : texte imprimé
Kazushi Yashima, Auteur ; Taku Obara, Auteur ; Fumiko Matsuzaki, Auteur |Introduction: Evaluation of the safety of taking lamotrigine (LTG) during lactation in breastfed infants varies according to the information sources. As it is possible that prescribers may avoid prescribing LTG despite of it being one of the ess[...]Article : texte imprimé
Information on general anesthesia and breastfeeding is incomplete, and often of poor quality, but some generalizations can be made. General anesthesia might delay lactation postoperatively somewhat, but nursing right before anesthesia might redu[...]Article : texte imprimé
Teresa Baker, Auteur ; Palika Datta, Auteur ; Kathleen Rewers-Felkins, Auteur |Background: Morbidly placenta accreta as a cause of postpartum morbidity is increasing in incidence. One conservative option is use of methotrexate as an adjuvant therapy for the management of placenta accreta. There is concern that use of metho[...]Article : texte imprimé
Kelly S. McGlothen, Auteur ; Lisa M. Cleveland, Auteur ; Sara L. Gill, Auteur |Background: Several professional health organizations have made statements endorsing the safety of breastfeeding for women taking medication-assisted treatment for an opioid use disorder. Yet, breastfeeding initiation rates for this population [...]Article : texte imprimé
Adetola Louis-Jacques, Auteur ; Ronée Wilson, Auteur ; Kathryn Dean, Auteur ; Ivonne Hernandez, Auteur ; Diane L. Spatz, Auteur ; Sarah Obican, Auteur |Objectives: To improve maternal knowledge on medication and substance usage during lactation through prenatal breastfeeding education and assess breastfeeding rates at 24 and 68 weeks postpartum. Study Design: This quality improvement initi[...]Article : texte imprimé
Induced Lactation in a Mother Through Surrogacy With Complete Androgen Insensitivity Syndrome (CAIS)
Magdalena LeCain, Auteur ; Gemma Fraterrigo, Auteur ; William M. Drake, Auteur |Introduction Breastfeeding offers the optimal feeding option for newborns in terms of nutritional content and reinforces mother-infant bonding. As a physiological process intrinsically linked to parturition, breastfeeding is no longer reserved [...]Article : texte imprimé
Ahmadai Hila, Auteur ; Andrew Crowe, Auteur ; Lisa BG Tee, Auteur |Despite the known risks associated with opioid use during breastfeeding, their place in therapy is established as part of a multimodal approach to treatment of pain in the early postpartum period. Opioids may be prescribed for post-caesarean ana[...]Article : texte imprimé
Marta Krenz-Niedbala, Auteur ; Krzysztof Koscinski, Auteur ; Elzbieta A. Puch, Auteur |Background: Studies of the protective effect of breastfeeding on asthma have not brought unequivocal results, and thus this issue remains controversial. Antibiotic use, known to increase asthma risk, may be involved in this relationship. The obj[...]Article : texte imprimé
Biologic medications are effective therapeutic options for treating autoimmune diseases, but information on their safety in lactation is still scarce. Autoimmune conditions occur frequently in women of childbearing age, creating difficult decisi[...]Article : texte imprimé
The LactMed database contains information on drugs to which breastfeeding mothers may be exposed, and the possible adverse effects of those medications in the nursing infant. LactMed is written under contract with the Specialized Information Ser[...]Article : texte imprimé
Carine Issa, Auteur ; Maria Hobeika, Auteur ; Rouba Karen Zeidam, Auteur |This study aims to investigate the positive association between a longer duration of breastfeeding and better health outcomes from birth to 36 months by using direct health outcomes and indirect health indicators. It is a cross-sectional study i[...]Article : texte imprimé
Lauren M. Jansson, Auteur ; Nancy Spencer, Auteur ; Krystle McConnell, Auteur |Background: In addition to the well-known benefits of human milk and breastfeeding for the mother and infant, breastfeeding may mitigate neonatal abstinence syndrome severity in prenatally opioid-exposed infants. However, lack of conclusive dat[...]texte imprimé
Ce guide s?ouvre sur une présentation de la physiologie de la lactation et de la pharmacocinétique des médicaments appliquée à la période de l?allaitement maternel. La prescription des médicaments en période d?allaitement est ensuite abordée par[...]Article : texte imprimé
For information on the use and safety of drugs in nursing mothers, the answers you get also depend on where you look for the answers. Several studies have compared the information provided in different sources. A 2007 article found wide variatio[...]Article : texte imprimé
Marita De Waard, Auteur ; Birgit S. Blomjous, Auteur ; Marinka L.F. Hol, Auteur |"Background: Medication use during pregnancy and lactation can be unavoidable, but knowledge on safety for the fetus or breastfed infant is limited among patients and healthcare providers. Research aim: This study aimed to determine (a) the[...]Article : texte imprimé
Sofia Colaceci, Auteur ; Angela Giusti, Auteur ; Alessia De Angelis, Auteur |Background: In cases of pharmacotherapy, mothers are confronted with the dilemma of breastfeeding and giving up the medication or discontinuing breastfeeding in order to take the drug, thus avoiding any potential risk for the infants. Object[...]Article : texte imprimé
It is feasible for migraineurs to breastfeed. If nondrug alternatives are ineffective, several prophylactic drugs such as certain anticonvulsants, beta-blockers, and onabotulinumtoxinA are safe for the breastfed infant. Although the new injectab[...]